Germany electroceuticals market is expected to grow at a CAGR of around 7% during the forecast period. The presence of quality healthcare system and favorable government policies is driving the market growth in the region. Further, noticeable numbers of Parkinson’s disease cases is also creating demand for electroceuticals in the region. Moreover, according to the Institute of Health Metrics and Evaluation, the value for the prevalence of Parkinson’s disease in 2013 was 32.10 million, which decreased up to 31.02 million in 2017. Parkinson’s disease is a common neurodegenerative disease, that impacts about 1% of the population of Germany over 65 years of age. 

The market is segmented on the basis of product and end-user. On the basis of product, the market is segmented into cardioverter defibrillators and cardiac pacemaker, deep brain stimulators (DBS), spinal cord stimulators (SCS), vagus nerve stimulators, hearing aids, and cochlear implants, and others such as sacral nerve stimulators, and transcutaneous electrical nerve stimulators. By end-user segment, the market is segmented into hospitals & clinics and homecare and other. 

Few players operating in the Germany electroceuticals market include Medtronic PLC, Biotronik Inc., Abbott Laboratories Inc., Boston Scientific Corp., LivaNova PLC, Cochlear, Ltd., Sonova Holding AG, Nevro Corp., ElectroCore LLC, and BioElectronics Corp. These players are adopting various strategies in order to expand its market share. For instance, in April 2019, Biotronik Inc. had launched Plexa ProMRI S DX lead, with DF4/IS-1 connector. The advancement in the DX technology offers whole atrial diagnostics in a single lead ICD and enables the timely detection of asymptomatic atrial fibrillation (AF). The launch of this device has made implant procedure simple by making less pressure on skin owing to its 10 mm slim size.   

Research Methodology

The market study of the Germany electroceuticals market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Germany Electroceuticals Market Research and Analysis by Product 
2. Germany Electroceuticals Market Research and Analysis by End-User

The Report Covers

• Comprehensive research methodology of the Germany electroceuticals market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Germany electroceuticals market.
• Insights about market determinants which are stimulating the Germany electroceuticals market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.